SCHEMBL1867923

SCHEMBL1867923

O=c1[nH]cnc2c1[N]C=N2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.40
PDPK1 O15530 5/20 0.34
PARP1 P09874 5/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
CA12 O43570 1/20 0.34
ALOX15 P16050 1/20 0.34
CA9 Q16790 1/20 0.34
TNKS2 Q9H2K2 1/20 0.34
TSHR P16473 2/20 0.33
LMNA P02545 1/20 0.33
ADORA2A P29274 1/20 0.33
SLC6A4 P31645 1/20 0.33
ADRA1A P35348 1/20 0.33
XDH P47989 1/20 0.33
RAB9A P51151 1/20 0.33
BLM P54132 1/20 0.33
HPGD P15428 1/20 0.32
KDM4A O75164 1/20 0.32
KDM4B O94953 1/20 0.32
KDM5C P41229 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL355917 0.83 ALDH1A1 (0.40) ALDH1A1PDPK1PARP1SMN1; SMN2CA12
SCHEMBL2790086 0.75 TDP1 (0.31) LMNA
SCHEMBL3245216 0.65 ALDH1A1 (0.39) ALDH1A1PDPK1PARP1SMN1; SMN2CA12
SCHEMBL29561093 0.65 ALDH1A1 (0.39) ALDH1A1PDPK1PARP1SMN1; SMN2CA12
SCHEMBL1919722 0.64
SCHEMBL14793587 0.64 ALDH1A1 (0.38) ALDH1A1PDPK1PARP1SMN1; SMN2CA12
SCHEMBL535022 0.64 QTRT1 (0.42) ALDH1A1ALOX15LMNAXDHBLM
SCHEMBL14793621 0.64 HPGD (0.38) ALDH1A1PDPK1PARP1SMN1; SMN2CA12
SCHEMBL4455591 0.64
SCHEMBL8468924 0.60 ALDH1A1 (0.41) ALDH1A1PDPK1PARP1SMN1; SMN2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2499142-A1 SUBSTITUTED FUSED PYRIMIDINE COMPOUNDS, ITS PREPARATION AND USES THEREOF Advinus Therapeutics Limited (IN) 2012-09-19 EP claimed
WO-2011055391-A1 SUBSTITUTED FUSED PYRIMIDINE COMPOUNDS, ITS PREPARATION AND USES THEREOF ADVINUS THERAPEUTICS PRIVATE LIMITED (IN) 2011-05-12 WO claimed
US-6060463-A Treatment of conditions of abnormally increased intraocular pressure by administration of phosphonylmethoxyalkyl nucleoside analogs and related nucleoside analogs Freeman, William (US) 2000-05-09 US claimed
US-5869468-A Treatment of conditions of abnormally increased intraocular pressure by administration of phosphonylmethoxyalkyl nucleoside analogs and related nucleoside analogs FREEMAN WILLIAM R (US) 1999-02-09 US claimed
EP-0754046-A1 USE OF PHOSPHONYLMETHOXYALKYL NUCLEOSIDES FOR THE TREATMENT OF RAISED INTRAOCULAR PRESSURE FREEMAN, William R. (US) 1997-01-22 EP claimed
WO-1995026734-A1 USE OF PHOSPHONYLMETHOXYALKYL NUCLEOSIDES FOR THE TREATMENT OF RAISED INTRAOCULAR PRESSURE FREEMAN WILLIAM R (US) 1995-10-12 WO claimed
EP-4587028-A2 COMPOUNDS AND METHODS FOR IMPROVING HEALTH Acurx Pharmaceuticals, Inc. (US) 2025-07-23 EP disclosed
WO-2024086579-A2 COMPOUNDS AND METHODS FOR IMPROVING HEALTH Acurx Pharmaceuticals, Inc. (US) 2024-04-25 WO disclosed
EP-4340827-A2 USE OF IBEZAPOLSTAT TO PROMOTE MICROBIOME HEALTH Acurx Pharmaceuticals, Inc. (US) 2024-03-27 EP disclosed
WO-2022266318-A2 USE OF IBEZAPOLSTAT TO PROMOTE MICROBIOME HEALTH ACURX PHARMACEUTICALS LLC (US) 2022-12-22 WO disclosed
EP-2499142-A1 SUBSTITUTED FUSED PYRIMIDINE COMPOUNDS, ITS PREPARATION AND USES THEREOF Advinus Therapeutics Limited (IN) 2012-09-19 EP disclosed
WO-2011055391-A1 SUBSTITUTED FUSED PYRIMIDINE COMPOUNDS, ITS PREPARATION AND USES THEREOF ADVINUS THERAPEUTICS PRIVATE LIMITED (IN) 2011-05-12 WO disclosed
EP-2185926-A1 METHOD FOR DIAGNOSING ACUTE CARDIAC ISCHEMIA Virginia Commonwealth University (US) 2010-05-19 EP disclosed
EP-0777417-A1 COMPOSITIONS AND METHODS FOR CONTROLLING PEST INSECTS VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) 1997-06-11 EP disclosed
US-5631259-A PURINE BASE DERIVATIVES FOR NUCLEOSIDES HOECHST AKTIENGESELLSCHAFT (DE) 1997-05-20 US disclosed
EP-0754046-A1 USE OF PHOSPHONYLMETHOXYALKYL NUCLEOSIDES FOR THE TREATMENT OF RAISED INTRAOCULAR PRESSURE FREEMAN, William R. (US) 1997-01-22 EP disclosed
WO-1996004791-A1 COMPOSITIONS AND METHODS FOR CONTROLLING PEST INSECTS VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) 1996-02-22 WO disclosed
WO-1995026734-A1 USE OF PHOSPHONYLMETHOXYALKYL NUCLEOSIDES FOR THE TREATMENT OF RAISED INTRAOCULAR PRESSURE FREEMAN WILLIAM R (US) 1995-10-12 WO disclosed
EP-0521463-A2 Substituted cyclic cycloalkyltriols, process, intermediates for their preparation and their use as antiviral and antiparasitic agents HOECHST AKTIENGESELLSCHAFT (DE) 1993-01-07 EP disclosed
US-4241168-A TWO-EQUIVALENT MAGENTA COUPLER FUJI PHOTO FILM CO., LTD. (JP) 1980-12-23 US disclosed